AllianceBernstein
IGC icon

AllianceBernstein’s IGC Pharma IGC Stock Holding History

AllianceBernstein’s Portfolio IGC Stock Details IGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-3,000
Closed -$1K – 3138
2015
Q1 		$1K Buy
+3,000
New +$1.62K ﹤0.01% 3496

Other funds holding IGC

VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

AllianceBernstein's IGC Position: Q2 2015 in Review

AllianceBernstein sold out of IGC Pharma (IGC) in Q2 2015, closing a stake of 3,000 shares — an estimated $1K sold.

AllianceBernstein first reported a position in IGC in Q1 2015 and held it in 1 quarter. The position peaked at $1K in Q1 2015. 6 funds tracked by Wall St. Rank hold IGC as of Q2 2015.

  • AllianceBernstein reported no remaining IGC Pharma position as of Q2 2015 after selling out during the quarter.
  • AllianceBernstein sold 3,000 IGC Pharma shares in Q2 2015, an estimated $1K.
  • AllianceBernstein first reported a position in IGC Pharma in Q1 2015 and held it in 1 quarter.
  • AllianceBernstein's IGC Pharma position peaked at $1K in Q1 2015.
  • 6 funds tracked by Wall St. Rank held IGC Pharma as of Q2 2015.

Based on AllianceBernstein's 13F filing for Q2 2015, filed 14 Aug 2015.